- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00143650
SENOC-I Det Sunda Huset II - Sensitization of Occupants of Water Damaged Buildings.
Does House Dust From Water Damaged Buildings Cause Stronger Responses Among Occupants Than Dust From Buildings Without Water Damage? Can Occupants' Sensitivity be Predicted by Biomarkers?
The study is focussed on two main questions:
- The importance of dampness of the building and home dust as a factor of the subjects= responses.
- Can measures used in KLINIR predict the subjects' responses to the dust?
This study therefore was arranged to test the following hypotheses:
- Does dust in general cause inflammatory/body perceptions through e.g. an irritation symptoms index.
- Does the dust include effective odorants which affects an IAQ index?
- Does dampness increase the content of organic or inorganic compounds e.g. of microbial origin that causes the dust to be more reactive? (Differences between the two types of dust)
- Is the sensitivity of the subjects explaining the responses to exposures in a, b, or c? (Subject group and sensitivity index)
As explorative investigations biomarkers for exposures and sensitivity for practical usage are tested.
Study Overview
Status
Intervention / Treatment
Detailed Description
The study is focussed on two main questions:
c. The importance of dampness of the building and home dust as a factor of the subjects= responses.
d. Can measures used in KLINIR predict the subjects' responses to the dust?
As explorative investigations biomarkers for exposures and sensitivity are tested for practical use.
These investigations are made during experimental exposures of subjects to dust from dry and water damaged buildings. The responses of healthy KLINIR-sensitive subjects are predicted using personal sensitivity measures.
The design is a 3x3 Latin square design (cross-over design). The subjects will be their own controls and comparisons to placebo (clean air) were made. The study was double blinded and the subjects were only informed about details on design and exposures after the experiment and only if they asked.
This design eliminated effects of any learning or training during the investigations, and also the effects of season and weekday was eliminated. The subjects were exposed with 3-4 weeks interval to eliminate carry-over of effects from one exposure session to the next.
The design was replicated three times on three different groups of subjects each including 9 subjects. Each group of nine were divided into three groups of three subjects.
Study Type
Enrollment
Phase
- Phase 2
- Phase 1
Contacts and Locations
Study Locations
-
-
-
Aarhus,, Denmark, DK-8000,
- The Air Pollution Unit, Department of Environmental and Occupational Medicine, Institute of Public Health, The University of Aarhus
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- All in local area, nasal histamine responsive, grass allergic, from study KLINIR.
Exclusion Criteria:
- Pregnancy, house dust allergy, hyper-responding air ways, disease, disabled
Study Plan
How is the study designed?
Design Details
- Primary Purpose: PREVENTION
- Allocation: NON_RANDOMIZED
- Interventional Model: CROSSOVER
- Masking: DOUBLE
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
|---|
|
Acoustic rhinometry, general symptoms, inflammation
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Lars Mølhave,, DMSc, Ph.D., The Air Pollution Unit, Department of Environmental and Occupational Medicine, Institute of Public Health, The University of Aarhus
Study record dates
Study Major Dates
Study Start
Study Completion
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ESTIMATE)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- FORMAS 24.2/2001-05
- SENOC,APU 0103.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.